FDA still not ready to go back to actual in-person meetings with biopharma sponsors

Since the Covid pandemic began in 2020, the FDA has shuttered its White Oak, MD, doors to outside companies not only seeking input on their developing assets, but for adcomm meetings too.

As of today, the FDA says nothing is changing in the near term with respect to a re-opening, although the agency has updated how it defines in-person meetings to include Zoom meetings with cameras on.